Please login to the form below
Communiqué Awards 2009: Finalists
Entries in the Education and Campaign categories have been reviewed and the list of finalists has now been published.
Entries in the Education and Campaign categories have been reviewed and the list of finalists published.
Once again there was considerable discussion and deliberation due the high standard of work submitted, but after much debate the finalists were confirmed and the winners will be presented on Thursday 9th July at the Grosvenor House hotel, in front of an audience of over 1000 guests from pharmaceutical and healthcare communications companies.
The judges praised excellent examples of best practice and were confident in the rigorous and transparent judging process. Entries in the premier categories will be judged next week and announced on PMLiVE on Friday 5th June. This year's charity is Admiral Nurses and PMGroup are delighted that John Suchet has agreed to speak at the awards to help raise much needed funds for this very worthwhile cause.
More information about the Communiqué Awards including details on how to book a table, online nomination forms for Communiquétor of the Year and the Communiqué Lifetime Achievement Award, along with details about sponsorship opportunites can be found in the dedicated Communiqué Awards section of PMLiVE.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Pfizer CEO pushes back COVID-19 vaccine submission to November
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- The Truth about Doctors
- Roche and Atea link up for oral COVID-19 drug; UK to test coronavirus vaccine T cell responses
- Novartis scores CHMP backing for cholesterol drug Leqvio
- Regeneron seeks US emergency use authorisation for COVID-19 antibody cocktail
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients
- Moderna completes enrolment of phase 3 COVID-19 vaccine trial
- Vaccine developers call on FDA to offer clarity on COVID-19 trials
- The other side of … blood cancer
- COVID-19 – a catalyst for technology adoption in clinical trials
PMHub
Envision Pharma Group
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...
Latest intelligence
- Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
- The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
- The other side of … blood cancer
- To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
- COVID-19 – a catalyst for technology adoption in clinical trials
- As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...
Quick links
Infographics
